The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to predict minimal residual disease prior to repeat-transurethral resection in high-risk non-muscle invasive bladder cancer (HR-NMIBC).
 
Joshua Linscott
Research Funding - Predicine
 
Hiroko Miyagi
Research Funding - Predicine
 
Billie Gould
Employment - Predicine
Stock and Other Ownership Interests - Predicine
Research Funding - Predicine
Travel, Accommodations, Expenses - Predicine
 
Prithvi Murthy
Research Funding - Predicine
 
Kyle M Rose
Research Funding - Predicine
 
Lucia P Camperlengo
Research Funding - Predicine
 
Giancarlo Bonora
Employment - Predicine
Stock and Other Ownership Interests - Predicine
Research Funding - Predicine
Travel, Accommodations, Expenses - Predicine
 
Logan Zemp
No Relationships to Disclose
 
Scott Michael Gilbert
No Relationships to Disclose
 
Philippe E. Spiess
Leadership - Global Society of Rare Genitourinary Tumors; NCCN; President of Global Society of Rare GU Tumors; Société Internationale d’Urologie Journal
Honoraria - UptoDate
Other Relationship - NCCN
(OPTIONAL) Uncompensated Relationships - Moffitt Cancer Center
 
Wade J. Sexton
Consulting or Advisory Role - pacific edge; UroGen pharma
 
Joshua J Meeks
Honoraria - Astellas Pharma; AstraZeneca; Imvax; incyte; Janssen; Merck; Pfizer; Prokarium; Urogen pharma
Research Funding - Epizyme; Merck Sharp & Dohme
Patents, Royalties, Other Intellectual Property - NMIBC genetic classifier (Inst); TCGA Classifier (Inst)
Other Relationship - Olympus
 
Pan Du
Employment - Predicine
Leadership - Predicine
Stock and Other Ownership Interests - Predicine
 
Shidong Jia
Employment - Genentech (I); Predicine
Leadership - Predicine
Stock and Other Ownership Interests - Predicine
Patents, Royalties, Other Intellectual Property - Liquid biopsy in cancer detection, therapy monitoring, MRD and early cancer detection
 
Roger Li
Stock and Other Ownership Interests - Beam Therapeutics; CRISPR therapeutics; Editas Medicine; Guardant Health; Intellia Therapeutics; Lilly
Consulting or Advisory Role - Bristol-Myers Squibb; CG Oncology; Lucence Diagnostics; Merck; Thericon
Research Funding - CG Oncology; Predicine; Valar Labs
Travel, Accommodations, Expenses - CG Oncology; Predicine
Other Relationship - Predicine